Berlin World Health Summit

[October 20, 2014]
Berlin, Germany

Since its first appearance in 2009, the World Health Summit (WHS) brings together opinion leaders from academia, politics, civil society, and the private sector to take responsibility in all health related challenges

Nathalie Strub-Wourgaft, DNDi Medical Director, spoke at a workshop on ethics in research and business.


Ethics in Research and Business

Date: October 20, 2014

Frédéric Dardel, Dean, Université Descartes Paris, France
François Bompart, Vice President, Deputy Head and Medical Director Access to Medicines, Sanofi, France

Bernd Carsten Stahl, Director, Center for Computing and Social Responsibility, School of Computer Science and Informatics, De Montfort University, United Kingdom
Innovation in ICT and Ethical Issues for the Health Industry
Isidoros Karatzas, Head of Ethics Sector, DG Research and Innovation, European Commission, Belgium
Legal and Ethical Dimensions of Responsible Innovation in the EU
Nathalie Strub-Wourgaft, Medical Director, DNDi, Switzerland
Improving the Quality of Host Country Ethical Oversight of International Research: The Use of a Collaborative “Pre-Review” Mechanism for a Study of Fexinidazole for Human African Trypanosomiasis
Paul Chew, Senior Vice, President Chief Medical Officer, Sanofi, France
Bioethics and Corporate Social Responsibility: What is at Stake for Private Companies?